Rikkunshito and isoliquiritigenin counteract 5-HT-induced 2C receptor-mediated activation of pro-opiomelanocortin neurons in the hypothalamic arcuate nucleus

Neuropeptides

Volumn 47, Issue 4, 2013, Pages 225-230

  Arai, Takeshi ^a   Maejima, Yuko ^a   Muroya, Shinji ^b   Yada, Toshihiko ^a,c  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b IMAMURA BUN IN HOSPITAL   (Japan)

^c NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

Author keywords

5 HT2C receptor; 5 Hydroxytryptamine; Anorexia; Arcuate nucleus; Pro opiomelanocortin; Rikkunshito

Indexed keywords

6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; CALCIUM; FURA 2; ISOLIQUIRITIGENIN; PROOPIOMELANOCORTIN; RIKKUNSHITO; SEROTONIN 2C ANTAGONIST; SEROTONIN 2C RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARCUATE NUCLEUS; ARTICLE; CELL ISOLATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG MECHANISM; IMMUNOCYTOCHEMISTRY; MALE; MICROFLUOROMETRY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SEROTONIN RELEASE; SIGNAL TRANSDUCTION; TRADITIONAL MEDICINE;

ANIMALS; ARCUATE NUCLEUS; CALCIUM; CALCIUM SIGNALING; CHALCONES; DRUGS, CHINESE HERBAL; ENZYME INHIBITORS; MALE; NEURONS; PRO-OPIOMELANOCORTIN; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN;

RATTUS;

EID: 84879782898     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2013.05.004     Document Type: Article

References (24)

1. Brambilla P., Cipriani A., Hotopf M., Barbui C. Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data. Pharmacopsychiatry 2005, 38:69-77.
2. De Vry J., Schreiber R. Effects of selected serotonin 5-HT1 and 5-HT2 receptor agonists on feeding behavior: possible mechanisms of action. Neurosci. Biobehav. Rev. 2000, 24:341-353.
3. Fujitsuka N., Asakawa A., Uezono Y., Minami K., Yamaguchi T., Niijima A., Yada T., Maejima Y., Sedvazar U., Sakai T., Hattori T., Kase Y., Inui A. Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival. Trans. Psychiat. 2011, 1:e23.
4. Halford J.C., Harrold J.A., Boyland E.J., Lawton C.L., Blundell J.E. Serotonergic drugs: effects on appetite expression and use for the treatment of obesity. Drugs 2007, 67:27-55.
5. Hattori T., Fujitsuka N., Amitani H., Asakawa A., Inui A. Rikkunshito, an Endogenous Signal Enhancer of Ghrelin, Improves Gastrointestinal Dysfunction. Ghrelin: Production, Action Mechanisms and Physiological Effects 2012, 127-141. Nova Science Publishers Inc., New York. H. Yamada, K. Takahashi (Eds.).
6. Heisler L.K., Cowley M.A., Tecott L.H., Fan W., Low M.J., Smart J.L., Rubinstein M., Tatro J.B., Marcus J.N., Holstege H., Lee C.E., Cone R.D., Elmquist J.K. Activation of central melanocortin pathways by fenfluramine. Science 2002, 297:609-611.
7. Kiev A., Feiger A. A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients. J. Clin. Psychiatry 1997, 58:146-152.
8. Kishi T., Elmquist J.K. Body weight is regulated by the brain: a link between feeding and emotion. Mol. Psychiatry 2005, 10:132-146.
9. Laviano A., Inui A., Marks D.L., Meguid M.M., Pichard C., Rossi Fanelli F., Seelaender M. Neural control of the anorexia-cachexia syndrome. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E1000-1008.
10. Maejima Y., Sedbazar U., Suyama S., Kohno D., Onaka T., Takano E., Yoshida N., Koike M., Uchiyama Y., Fujiwara K., Yashiro T., Horvath T.L., Dietrich M.O., Tanaka S., Dezaki K., Oh-I S., Hashimoto K., Shimizu H., Nakata M., Mori M., Yada T. Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab. 2009, 10:355-365.
11. Muroya S., Funahashi H., Yamanaka A., Kohno D., Uramura K., Nambu T., Shibahara M., Kuramochi M., Takigawa M., Yanagisawa M., Sakurai T., Shioda S., Yada T. Orexins (hypocretins) directly interact with neuropeptide Y, POMC and glucose-responsive neurons to regulate Ca 2+ signaling in a reciprocal manner to leptin: orexigenic neuronal pathways in the mediobasal hypothalamus. Eur. J. Neurosci. 2004, 19:1524-1534.
12. Nonogaki K., Strack A.M., Dallman M.F., Tecott L.H. Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nat. Med. 1998, 4:1152-1156.
13. Oka T., Tamagawa Y., Hayashida S., Kaneda Y., Kodama N., Tsuji S. Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine. Biopsycho. Soc. Med. 2007, 1:1-6.
14. Takeda H., Sadakane C., Hattori T., Katsurada T., Ohkawara T., Nagai K., Asaka M. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology 2008, 134:2004-2013.
15. Tatsuta M., Iishi H. Effect of treatment with liu-jun-zi-tang(TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients. Aliment. Pharmacol. Ther. 1993, 7:459-462.
16. Tecott L.H., Sun L.M., Akana S.F., Strack A.M., Lowenstein D.H., Dallman M.F., Julius D. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 1995, 374:542-546.
17. Tomono H., Ito Y., Watanabe T. Successful antiemetic treatment of Tsumura rikkunshi-to extract granules for ethical use in addition to other antiemetic agents in neoadjuvant chemotherapy for an advanced breast cancer patient. Gan To Kagaku Ryoho 2006, 33:1129-1131.
18. Ueda N., Yoshimura R., Shinkai K., Sakata Y., Nakamura J. Higher plasma 5-hydroxyindoleacetic acid levels are associated with SSRI-induced nausea. Neuropsychobiology 2003, 48:31-34.
19. Xu Y., Jones J.E., Kohno D., Williams K.W., Lee C.E., Choi M.J., Anderson J.G., Heisler L.K., Zigman J.M., Lowell B.B., Elmquist J.K. 5-HT2CRs expressed by pro-opiomelanocortin neurons regulate energy homeostasis. Neuron 2008, 26:582-589.
20. Yada T., Kohno D., Maejima Y., Sedbazar U., Arai T., Toriya M., Maekawa F., Kurita H., Niijima A., Yakabi K. Neurohormones, rikkunshito and hypothalamic neurons interactively control appetite and anorexia. Curr. Pharm. Des. 2012, [Epub ahead of print].
21. Yada T., Vigh S., Arimura A. Pituitary adenylate cyclase activating polypeptide (PACAP) increases cytosolic-free calcium concentration in folliculo-stellate cells and somatotropes of rat pituitary. Peptides 1993, 14:235-239.
22. Yagi M., Homma S., Kubota M., Iinuma Y., Kanada S., Kinoshita Y., Ohtaki M., Yamazaki S., Murata H. The herbal medicine Rikkunshi-to stimulates and coordinates the gastric myoelectric activity in post-operative dyspeptic children after gastrointestinal surgery. Pediatr. Surg. Int. 2004, 19:760-765.
23. Youdim K.A., Dobbie M.S., Kuhnle G., Proteggente A.R., Abbott N.J., Rice-Evans C. Interaction between flavonoids and the blood-brain barrier: in vitro studies. J. Neurochem. 2003, 85:180-192.
24. Zhang L., Yagi M., Herzog H. The role of NPY and Ghrelin in anorexia nervosa. Curr. Pharm. Des. 2012, [Epub ahead of print].